“…Polymer-based nanoparticles can be used as the carrier for numerous biologically active molecules including drugs [18], proteins [7], monoclonal antibodies [13], nucleic acids [19,20], biological extracts [16,21] and others [22]. This review will be especially concerned with the application of polymer-based nanoparticles for the treatment of various disease entities including bacterial [23,24], fungal [25] and parasitic [26] infections, ulcers [11], hypertension [12], angina [8], glaucoma [9], uveitis [27], asthma [22], cancer [15,28], neurodegenerative disease [29] and many others [30,31]. It deserves to be emphasized that several polymers are characterized by satisfying biocompatibility and predictable biodegradability [9,22] while others are non-degradable or undergo slow degradation [22,32].…”